NDC Pharmacologic Class N0000193859 Tropomyosin Receptor Kinases Inhibitors [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
50419-390Vitrakvi LarotrectinibCapsuleOralBayer Healthcare Pharmaceuticals Inc.Human Prescription Drug
50419-391Vitrakvi LarotrectinibCapsuleOralBayer Healthcare Pharmaceuticals Inc.Human Prescription Drug
50419-392Vitrakvi LarotrectinibSolution, ConcentrateOropharyngealBayer Healthcare Pharmaceuticals Inc.Human Prescription Drug
71777-390Vitrakvi LarotrectinibCapsuleOralLoxo Oncology, Inc.Human Prescription Drug
71777-391Vitrakvi LarotrectinibCapsuleOralLoxo Oncology, Inc.Human Prescription Drug
71777-392Vitrakvi LarotrectinibSolutionOralLoxo Oncology, Inc.Human Prescription Drug

There are 6 NDC products with the pharmacologic class Tropomyosin Receptor Kinases Inhibitors [MoA].